This is a single-center, double-blind, randomized, placebo-controlled clinical trial.
Peripartum and postpartum Activin A are significantly elevated in women with preeclampsia.
Our hypothesis is that elevated Activin A levels reflect a remediable signal and that
reducing postpartum Activin A levels with aspirin therapy will improve Global Longitudinal
Strain (GLS) in preeclamptic patients.